Career Enhancement Program (CEP)

摘要 这项职业提升计划的目的是支持有前途的研究人员参与 转化型乳腺癌研究项目。任何时候都有一到两个获奖者，他们可能是 医学博士或博士学位。候选人是根据他们以前的成就和潜力来挑选的。 渴望从事乳腺癌学术研究的愿望。虽然我们的主要重点是支持有希望的 初级教员级别的年轻调查人员，可能更成熟的调查人员也可能是 适用于支持。 每个获奖者的研究大体轮廓将由申请者和选拔人员讨论 委员会作为遴选过程的一部分，并同意从项目系中选出一名主要导师 在那里。获奖者将从执行委员会和选定的导师那里获得进一步的指导 在整个获奖期间开发他们的翻译研究项目。他们还将参加一项 广泛的研讨会、专业发展课程和临床机会。 贝勒乳房中心的研究环境非常适合支持翻译活动。科学 乳腺癌研究的卓越继续通过个人和合作奖的颁发而得到重申 拨款，而国家和地方的临床研究计划都在贝勒乳房很好地建立起来 中心，并可协助将研究成果转化为临床实践。这是一款极好的 加强优秀研究人员的职业生涯并将其集中于富有成效的翻译研究的背景 在乳腺癌方面。事实上，在26年中从该项目获得部分支持的21名年轻调查人员中 自从我们的第一个孢子奖以来，大多数人都活跃在乳腺癌的学术研究职位上，还有四个 在这个新的孢子提案中扮演重要角色，包括一名项目负责人。

Abstract The purpose of this Career Enhancement Program is to support promising investigators who will participate in translational breast cancer research projects. There are one to two awardees at any one time, who may be either MD's or PhD's. Candidates are selected based on their previous accomplishments and their potential and desire to pursue a career in academic breast cancer research. While our primary focus is to support promising young investigators at the junior faculty level, it is possible that more established investigators may also be appropriate for support. The general outline of each awardee’s research will have been discussed by the applicant and the Selection Committee as a part of the selection process, and a principal mentor from the Program Faculty will be agreed upon. Awardees will receive further guidance from the Executive Committee and the selected mentor in developing their translational research projects throughout the award period. They will also participate in an extensive set of seminars, professional development courses, and clinical opportunities. The research environment at the Baylor Breast Center is ideal for supporting translational activities. Scientific excellence in breast cancer research continues to be reaffirmed by the award of both individual and collaborative grants, while both national and local programs of clinical investigation are well established at the Baylor Breast Center and can serve to assist in the translation of research findings into clinical practice. This is an excellent setting for enhancing and focusing the careers of outstanding investigators on productive translational research in breast cancer. Indeed, of the 21 young investigators who received partial support from this program in the 26 years since our first SPORE award, most are active in academic research positions in breast cancer, and four have important roles in this new SPORE proposal including one project leader.